iCAD, Inc. (NASDAQ:ICAD) Shares Acquired by First Eagle Investment Management LLC

First Eagle Investment Management LLC lifted its position in iCAD, Inc. (NASDAQ:ICADFree Report) by 6.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 716,161 shares of the technology company’s stock after acquiring an additional 41,000 shares during the period. First Eagle Investment Management LLC owned 2.70% of iCAD worth $1,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Summit Trail Advisors LLC purchased a new stake in shares of iCAD in the 4th quarter valued at $214,000. Thompson Davis & CO. Inc. purchased a new stake in iCAD in the fourth quarter valued at $31,000. Finally, waypoint wealth counsel grew its position in iCAD by 44.0% during the 4th quarter. waypoint wealth counsel now owns 14,400 shares of the technology company’s stock worth $26,000 after purchasing an additional 4,400 shares during the period. Hedge funds and other institutional investors own 24.61% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of iCAD from a “sell” rating to a “hold” rating in a research note on Thursday, February 20th.

Get Our Latest Stock Analysis on ICAD

iCAD Stock Up 4.6 %

ICAD opened at $2.29 on Monday. The company has a market cap of $60.78 million, a PE ratio of -17.62 and a beta of 1.95. iCAD, Inc. has a twelve month low of $1.18 and a twelve month high of $3.78. The company has a 50-day moving average price of $2.62 and a 200 day moving average price of $2.04.

iCAD Company Profile

(Free Report)

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.

Further Reading

Institutional Ownership by Quarter for iCAD (NASDAQ:ICAD)

Receive News & Ratings for iCAD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCAD and related companies with MarketBeat.com's FREE daily email newsletter.